National and Kapodistrian University of Athens
Ποσοτική μέτρηση του πεπτιδίου ενδοθηλίνη -1 στη φλεβική και αρτηριακή κυκλοφορία διασωληνωμένων ασθενών με νόσο Covid-19
Abstract
dc:descriptionThe COVID-19 pandemic (2019-2022) has prompted rapid mobilization from the scientific community to clarify the pathogenesis of acute respiratory distress syndrome (ARDS) in COVID-19. Clinical data indicate that COVID-19 often presents as a syndrome of acute respiratory distress caused by viral pneumonia (ARDS) in patients with pre-existing endothelial dysfunction due to multiple comorbidities (hypertension, coronary artery disease, respiratory diseases, diabetes), while obesity and male gender are additional exacerbating factors. Similarly, advanced age has been identified as one of the main risk factors for developing severe clinical disease due to the SARS-CoV-2 virus. The endothelium is a cell layer lining the inner surface of blood vessels (arteries, veins, capillaries) and the heart. It plays a crucial role in regulating vascular permeability, blood flow, coagulation, vasoconstriction, vasodilation, and the body’s response to inflammatory conditions. Additionally, it actively participates in the process of angiogenesis. As such, endothelial dysfunction is linked to many diseases, such as hypertension, atherosclerosis, and other cardiovascular diseases. Endothelin (ET-1) is a potent vasoconstrictor protein primarily produced by endothelial cells, which line the inner surface of blood vessels. In healthy pulmonary circulation, the production rate of endothelin-1 is nearly identical to its clearance rate. The objective of the proposed Doctoral Dissertation is the quantification of endothelin-1 peptide levels in the venous and arterial circulation, as well as the assessment of its metabolism (clearance) in pulmonary function, in relation to the clinical deterioration of intubated patients suffering from Acute Respiratory Distress Syndrome (ARDS) due to COVID-19 infection. More specifically, the levels of endothelin-1 were studied in intubated patients with a confirmed diagnosis of SARS-CoV-2 (RT-PCR test), as well as the arterial-to-venous endothelin-1 ratio (A:V). This approach allowed us to indirectly calculate the metabolism of endothelin-1 in patients with ARDS and COVID-19, aiming to explore the potential link between elevated levels or dysregulated clearance of endothelin-1 in the pulmonary circulation and poor prognosis in patients with Acute Respiratory Distress Syndrome (ARDS) and COVID-19 disease. The need for recording these data, particularly the long-term outcomes, arises from the lack of corresponding international clinical and laboratory records that correlate endothelin-1 peptide levels and its metabolism in the pulmonary circulation with the clinical course of intubated patients with acute respiratory distress syndrome in the context of COVID-19 infection.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Roumpaki, Anastasia
- Ρουμπάκη, Αναστασία
Subjects
dc:subject × 23- COVID-19
- Ενδοθηλίνη-1
- Ενδοθηλιακή δυσλειτουργία
- Σύνδρομο οξείας αναπνευστικής δυσχέρειας
- Διασωληνωμένοι ασθενείς
- Μηχανικός αερισμός
- Βιοδείκτες
- Μονάδα εντατικής θεραπείας
- Μόρια προσκόλλησης ενδοθηλίνης
- Endothelin-1
- Endothelial dysfunction
- Acute respiratory distress syndrome
- Intubated patients
- Mechanical ventilation
- Biomarkers
- Intensive care unit
- Endothelin adhesion molecules
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Γενική και Εσωτερική ιατρική
- Clinical Medicine
- Medical and Health Sciences
- General and Internal Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/59105